The association between PD-1 gene polymorphisms and susceptibility to multiple sclerosis

Area of Science:

• Immunogenetics
• Neuroimmunology
• Human Genetics

Background:

• Programmed Cell Death 1 (PD-1) is a critical immune checkpoint protein.
• PD-1 dysregulation is implicated in various autoimmune diseases.
• The role of PD-1 gene polymorphisms in multiple sclerosis (MS) pathogenesis remains under investigation.

Purpose of the Study:

• To examine the association between specific human PD-1 gene (PDCD1) polymorphisms and multiple sclerosis (MS).
• To investigate the potential genetic susceptibility conferred by PD-1.1, PD-1.3, and PD-1.5 variants in MS patients.

Main Methods:

• A case-control study involving 229 MS patients and 246 healthy controls.
• Genotyping of PDCD1 polymorphisms rs36084323 (PD-1.1), rs11568821 (PD-1.3), and rs2227981 (PD-1.5) using PCR-RFLP.
• Statistical analysis to compare genotype and allele frequencies between cases and controls.

Main Results:

• No significant difference in PD-1.1 (rs36084323) genotype or allele frequencies between MS patients and controls.
• The AA+AG genotype of PD-1.3 (rs11568821) was more prevalent in the control group.
• A trend towards higher frequency of T allele carriers (TT+CT) in PD-1.5 (rs2227981) was observed in MS patients (p=0.07).

Conclusions:

• PD-1 gene polymorphisms, particularly PD-1.5, may have a subtle association with multiple sclerosis susceptibility.
• The observed trends require validation in larger, independent cohorts.
• Further investigation into PD-1 genetic variations is warranted to elucidate their role in MS pathogenesis.